Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 10/2008

01-10-2008 | Case Report

TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss

Authors: Marco Caversaccio, Harald Marcel Bonél, Rachel Carter, Anthony P. Williams, Stephan D. Gadola

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2008

Login to get access

Abstract

Nose–ear–throat manifestations of immunodeficiency disorders represent a diagnostic challenge for clinicians as these diseases often constitute the initial sign for connective disorders or autoimmune disease. The history of chronic rhinosinusitis and conductive hearing loss is often non specific. Therefore attention to an HLA class I deficiency must be considered if the disease has not been diagnosed on routine examination. One of the syndromes is due to a defective TAP complex, the peptide transporter complex associated with antigen presentation. Herein, we report two sisters with TAP-deficiency. The treatment of choice for TAP-deficient patients is conservative.
Literature
1.
go back to reference Pamer E, Cresswell P (1998) Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16:323–358PubMedCrossRef Pamer E, Cresswell P (1998) Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16:323–358PubMedCrossRef
2.
go back to reference Colonna M (1997) Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 155:127–133PubMedCrossRef Colonna M (1997) Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 155:127–133PubMedCrossRef
3.
go back to reference Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerandolo V (2000) TAP deficiency syndrome. Clin Exp Immunol 121:173–178PubMedCrossRef Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerandolo V (2000) TAP deficiency syndrome. Clin Exp Immunol 121:173–178PubMedCrossRef
4.
go back to reference Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443–448PubMedCrossRef Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443–448PubMedCrossRef
5.
go back to reference Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baycal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 354:1598–1603PubMedCrossRef Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baycal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 354:1598–1603PubMedCrossRef
6.
go back to reference Rasmussen N (2001) Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol 13:3–11PubMedCrossRef Rasmussen N (2001) Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s perspective. Curr Opin Rheumatol 13:3–11PubMedCrossRef
7.
go back to reference Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT (2004) Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 22:485–494PubMed Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT (2004) Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 22:485–494PubMed
8.
go back to reference De la Salle H, Zimmer J, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falkenrodt A, Cazenave JP, Trowsdale J, Tongio MM (1999) HLA class I deficiencies due to mutations in subunit 1 of peptide transporter TAP1. J Clin Invest 103:9–13CrossRef De la Salle H, Zimmer J, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falkenrodt A, Cazenave JP, Trowsdale J, Tongio MM (1999) HLA class I deficiencies due to mutations in subunit 1 of peptide transporter TAP1. J Clin Invest 103:9–13CrossRef
Metadata
Title
TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss
Authors
Marco Caversaccio
Harald Marcel Bonél
Rachel Carter
Anthony P. Williams
Stephan D. Gadola
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 10/2008
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-008-0610-3

Other articles of this Issue 10/2008

European Archives of Oto-Rhino-Laryngology 10/2008 Go to the issue